Literature DB >> 2292083

Calcitonin, osteoclasts, and bone turnover.

S Wallach1, J B Carstens, L V Avioli.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 2292083     DOI： 10.1007/bf02555892

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN： 0171-967X            Impact factor:   4.333


× No keyword cloud information.
  4 in total

1.  Tartrate-resistant acid phosphate activity as osteoclastic marker: sensitivity of cytochemical assessment and serum assay in comparison with standardized osteoclast histomorphometry.

Authors:  P Ballanti; S Minisola; M T Pacitti; L Scarnecchia; R Rosso; G F Mazzuoli; E Bonucci
Journal:  Osteoporos Int       Date:  1997       Impact factor: 4.507

2.  Prevention of ovariectomy osteopenia in rats after vaginal administration of Hyaff 11 microspheres containing salmon calcitonin.

Authors:  E Bonucci; P Ballanti; P A Ramires; J L Richardson; L M Benedetti
Journal:  Calcif Tissue Int       Date:  1995-04       Impact factor: 4.333

Review 3.  Management of osteoporosis and Paget's disease. An appraisal of the risks and benefits of drug treatment.

Authors:  C Gennari; R Nuti; D Agnusdei; A Camporeale; G Martini
Journal:  Drug Saf       Date:  1994-09       Impact factor: 5.606

Review 4.  Locally Applied Repositioned Hormones for Oral Bone and Periodontal Tissue Engineering: A Narrative Review.

Authors:  Gamal Abdel Nasser Atia; Hany K Shalaby; Mehrukh Zehravi; Mohamed Mohamady Ghobashy; Zubair Ahmad; Farhat S Khan; Abhijit Dey; Md Habibur Rahman; Sang Woo Joo; Hasi Rani Barai; Simona Cavalu
Journal:  Polymers (Basel)       Date:  2022-07-21       Impact factor: 4.967
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.